Brown Brothers Harriman & CO Electro Core, Inc. Transaction History

Brown Brothers Harriman & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.19 - $2.06 $11,900 - $20,600	-10,000 Reduced 33.33%	20,000 $24,000
Q1 2021 May 13, 2021	BUY	$1.62 - $3.05 $16,200 - $30,500	10,000 Added 50.0%	30,000 $62,000
Q4 2020 Feb 16, 2021	SELL	$1.44 - $1.98 $57,600 - $79,200	-40,000 Reduced 66.67%	20,000 $31,000
Q3 2019 Nov 14, 2019	BUY	$1.25 - $5.0 $25,000 - $100,000	20,000 Added 50.0%	60,000 $131,000
Q2 2019 Aug 14, 2019	BUY	$1.65 - $6.72 $33,000 - $134,400	20,000 Added 100.0%	40,000 $80,000
Q4 2018 Feb 14, 2019	BUY	$4.21 - $14.28 $42,100 - $142,800	10,000 Added 100.0%	20,000 $125,000
Q3 2018 Nov 14, 2018	BUY	$13.02 - $17.54 $130,200 - $175,400	10,000 New	10,000 $140,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $523M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.